We next assessed if different clinical factors, including anemia, stunting status, and environmental enteric disease (measured through the inflammatory markers fecal calprotectin and alpha-1-antitrypsin) are associated with significant changes in the eukaryome composition in the GI tract (Figure 2 and 3; Figure S7B, Supporting Information). Here, SERPINA1 is linked to anemia.